A carregar...
Rifaximin, gut microbes and mucosal inflammation: unraveling a complex relationship
Rifaximin is a non-systemic, broad-spectrum antibiotic that acts against gram-positive, gram-negative, and anaerobic bacteria. Clinical studies indicate that rifaximin is beneficial in treating irritable bowel syndrome (IBS). The mechanism responsible for the beneficial effects of rifaximin is not c...
Na minha lista:
| Publicado no: | Gut Microbes |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5915365/ https://ncbi.nlm.nih.gov/pubmed/25244596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/gmic.32130 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|